Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT00001867
Eligibility Criteria:
Females with a history of unilateral or bilateral immune-mediated, non-infectious inflammatory ocular disease that required topical and/or systemic immunosuppresive medications at least once in the past two years or who are currently under treatment for unilateral or bilateral non-infectious ocular inflammation and having diagnosed uveitis, scleritis, or autoimmune corneal disorders in the past two years.
First and second trimester pregnancy.
Informed consent from the patient.
No pregnancy complications which require medical treatment and special obstetric care.
No hematolgical disorder that would preclude blood draws for investigational purposes.
No current ocular or systemic infection.
No current malignancy.
No current endocrine disorders.
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00001867
Study Brief:
Protocol Section:
NCT00001867